Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
Ann Intern Med
.
2021 Apr;174(4):581-582.
doi: 10.7326/L20-1399.
Authors
Julia Del Amo
1
,
Rosa Polo
1
,
Santiago Moreno
2
,
Asunción Díaz
3
,
Esteban Martínez
4
,
José Ramón Arribas
5
,
Inma Jarrín
6
,
Miguel A Hernán
7
Affiliations
1
Ministry of Health, Madrid, Spain.
2
University Hospital Ramón y Cajal and HIV Network of Excellence, Madrid, Spain.
3
Institute of Health Carlos III, Ministry of Health, and HIV Network of Excellence, Madrid, Spain.
4
University Hospital Clinic, Barcelona, Spain, and HIV Network of Excellence, Madrid, Spain.
5
University Hospital La Paz, IdiPAZ, and HIV Network of Excellence, Madrid, Spain.
6
Institute of Health Carlos III and HIV Network of Excellence, Madrid, Spain.
7
Harvard T.H. Chan School of Public Health and Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts.
PMID:
33872541
DOI:
10.7326/L20-1399
No abstract available
Publication types
Letter
Kommentar
MeSH terms
Antiretroviral Therapy, Highly Active
COVID-19*
HIV Infections* / complications
HIV Infections* / drug therapy
HIV Infections* / epidemiology
Humans
Incidence
SARS-CoV-2